317 related articles for article (PubMed ID: 17651754)
1. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.
Olivares I; Mulky A; Boross PI; Tözsér J; Kappes JC; López-Galíndez C; Menéndez-Arias L
J Mol Biol; 2007 Sep; 372(2):369-81. PubMed ID: 17651754
[TBL] [Abstract][Full Text] [Related]
2. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
Abram ME; Parniak MA
J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
Sluis-Cremer N; Arion D; Abram ME; Parniak MA
Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
[TBL] [Abstract][Full Text] [Related]
4. Interplay between protease and reverse transcriptase dimerization in a model HIV-1 polyprotein.
Chagas BCA; Zhou X; Guerrero M; Ilina TV; Ishima R
Protein Sci; 2024 Jul; 33(7):e5080. PubMed ID: 38896002
[TBL] [Abstract][Full Text] [Related]
5. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.
Mulky A; Vu BC; Conway JA; Hughes SH; Kappes JC
J Mol Biol; 2007 Feb; 365(5):1368-78. PubMed ID: 17141805
[TBL] [Abstract][Full Text] [Related]
6. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
Mulky A; Sarafianos SG; Jia Y; Arnold E; Kappes JC
J Mol Biol; 2005 Jun; 349(4):673-84. PubMed ID: 15893326
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
Hsieh SH; Yu FH; Huang KJ; Wang CT
J Virol; 2023 Sep; 97(9):e0094823. PubMed ID: 37671867
[TBL] [Abstract][Full Text] [Related]
8. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
Wapling J; Moore KL; Sonza S; Mak J; Tachedjian G
J Virol; 2005 Aug; 79(16):10247-57. PubMed ID: 16051818
[TBL] [Abstract][Full Text] [Related]
9. Glutamic residue 438 within the protease-sensitive subdomain of HIV-1 reverse transcriptase is critical for heterodimer processing in viral particles.
Navarro JM; Damier L; Boretto J; Priet S; Canard B; Quérat G; Sire J
Virology; 2001 Nov; 290(2):300-8. PubMed ID: 11883194
[TBL] [Abstract][Full Text] [Related]
10. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
[TBL] [Abstract][Full Text] [Related]
11. The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.
Boso G; Örvell C; Somia NV
J Virol; 2015 Jan; 89(2):1286-97. PubMed ID: 25392207
[TBL] [Abstract][Full Text] [Related]
12. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161
[TBL] [Abstract][Full Text] [Related]
13. Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors.
Nishitsuji H; Yokoyama M; Sato H; Yamauchi S; Takaku H
FEBS Lett; 2011 Nov; 585(21):3372-7. PubMed ID: 22004763
[TBL] [Abstract][Full Text] [Related]
14. The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.
Abram ME; Sarafianos SG; Parniak MA
Retrovirology; 2010 Feb; 7():6. PubMed ID: 20122159
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan scanning mutagenesis of aromatic residues within the polymerase domain of HIV-1 reverse transcriptase: critical role of Phe-130 for p51 function and second-site revertant restoring viral replication capacity.
Olivares I; Gutiérrez-Rivas M; López-Galíndez C; Menéndez-Arias L
Virology; 2004 Jul; 324(2):400-11. PubMed ID: 15207625
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine.
Sluis-Cremer N; Dmitrienko GI; Balzarini J; Camarasa MJ; Parniak MA
Biochemistry; 2000 Feb; 39(6):1427-33. PubMed ID: 10684624
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HIV type 1 reverse transcriptase expression in a human cell line.
Ansari-Lari MA; Gibbs RA
AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1117-24. PubMed ID: 7530025
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.
Huang W; Gamarnik A; Limoli K; Petropoulos CJ; Whitcomb JM
J Virol; 2003 Jan; 77(2):1512-23. PubMed ID: 12502865
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
Yu FH; Wang CT
Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
[TBL] [Abstract][Full Text] [Related]
20. Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.
Bleiber G; Munoz M; Ciuffi A; Meylan P; Telenti A
J Virol; 2001 Apr; 75(7):3291-300. PubMed ID: 11238855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
